心血管病防治知识（下半月）
心血管病防治知識（下半月）
심혈관병방치지식（하반월）
XINXUEGUANBING FANGZHI ZHISHI
2015年
5期
15-17
,共3页
硫酸镁%硝苯地平%妊娠高血压综合征%临床疗效
硫痠鎂%硝苯地平%妊娠高血壓綜閤徵%臨床療效
류산미%초분지평%임신고혈압종합정%림상료효
Magnesium sulfate%Nifedipine%Pregnancy-induced hypertension%Clinical efficacy
目的：分析硫酸镁联合硝苯地平治疗妊娠高血压综合征患者的临床效果。方法抽选2011年9月-2014年10月，我院接收妊娠高血压综合征患者80例，按入院时间分成两组（医治组、对照组），对照组患者给予硫酸镁药物治疗，医治组患者给予硫酸镁联合硝苯地平治疗，比对两组患者治疗效果。结果医治组患者临床治疗好转率和对照组相比，差异明显，统计学意义突出（P＜0.05）；且医治组患者收缩压、舒张压等相应指标和对照组患者相比，均存在明显性临床差异，统计学意义突出（P＜0.05）。结论借助硫酸镁联合硝苯地平治疗妊娠高血压综合征患者，效果明显，可缓解患者临床症状，提高好转率，意义重大，值得推广。
目的：分析硫痠鎂聯閤硝苯地平治療妊娠高血壓綜閤徵患者的臨床效果。方法抽選2011年9月-2014年10月，我院接收妊娠高血壓綜閤徵患者80例，按入院時間分成兩組（醫治組、對照組），對照組患者給予硫痠鎂藥物治療，醫治組患者給予硫痠鎂聯閤硝苯地平治療，比對兩組患者治療效果。結果醫治組患者臨床治療好轉率和對照組相比，差異明顯，統計學意義突齣（P＜0.05）；且醫治組患者收縮壓、舒張壓等相應指標和對照組患者相比，均存在明顯性臨床差異，統計學意義突齣（P＜0.05）。結論藉助硫痠鎂聯閤硝苯地平治療妊娠高血壓綜閤徵患者，效果明顯，可緩解患者臨床癥狀，提高好轉率，意義重大，值得推廣。
목적：분석류산미연합초분지평치료임신고혈압종합정환자적림상효과。방법추선2011년9월-2014년10월，아원접수임신고혈압종합정환자80례，안입원시간분성량조（의치조、대조조），대조조환자급여류산미약물치료，의치조환자급여류산미연합초분지평치료，비대량조환자치료효과。결과의치조환자림상치료호전솔화대조조상비，차이명현，통계학의의돌출（P＜0.05）；차의치조환자수축압、서장압등상응지표화대조조환자상비，균존재명현성림상차이，통계학의의돌출（P＜0.05）。결론차조류산미연합초분지평치료임신고혈압종합정환자，효과명현，가완해환자림상증상，제고호전솔，의의중대，치득추엄。
Objective To evaluate the clinical efficacy of magnesium sulfate and nifedipine in the treatment of pregnancy-induced hypertension (PIH). Methods Totally 80 cases of PIH admitted to our hospital from September 2011 to October 2014 were selected randomly and divided into two groups according to the admission time: treatment group and control group. The control group was treated with magnesium sulfate and the treatment group was treated with magnesium sulfate plus nifedipine. Then the clinical efficacy was compared between the two groups. Results The improvement rate in the treatment group was significantly higher than that in the control group (P<0.05). In addition, there were significant differences in systolic pressure and diastolic blood pressure between the treatment group and the control group (P<0.05). Conclusion The combination therapy with magnesium sulfate and nifedipine has significant efficacy for PIH in terms of clinical symptoms and improvement rate, and it holds promise for clinical application.
